Genes & Nutrition

, Volume 6, Issue 1, pp 5–16

Unleashing the untold and misunderstood observations on vitamin E

Review

Abstract

Paradoxically, meta-analysis of human randomized controlled trials revealed that natural but not synthetic α-tocopherol supplementation significantly increases all-cause mortality at 95% confidence interval. The root cause was that natural α-tocopherol supplementation significantly depressed bioavailability of other forms of vitamin E that have better chemo-prevention capability. Meta-analysis outcome demonstrated flaws in the understanding of vitamin E. Reinterpretation of reported data provides plausible explanations to several important observations. While α-tocopherol is almost exclusively secreted in chylomicrons, enterocytes secrete tocotrienols in both chylomicrons and small high-density lipoproteins. Vitamin E secreted in chylomicrons is discriminately repacked by α-tocopherol transfer protein into nascent very low-density lipoproteins in the liver. Circulating very low-density lipoproteins undergo delipidation to form intermediate-density lipoproteins and low-density lipoproteins. Uptake of vitamin E in intermediate-density lipoproteins and low-density lipoproteins takes place at various tissues via low-density lipoproteins receptor–mediated endocytosis. Small high-density lipoproteins can deliver tocotrienols upon maturation to peripheral tissues independent of α-tocopherol transfer protein action, and uptake of vitamin E takes place at selective tissues by scavenger receptor–mediated direct vitamin E uptake. Dual absorption pathways for tocotrienols are consistent with human and animal studies. α-Tocopherol depresses the bioavailability of α-tocotrienol and has antagonistic effect on tocotrienols in chemo-prevention against degenerative diseases. Therefore, it is an undesirable component for chemo-prevention. Future research directions should be focused on tocotrienols, preferably free from α-tocopherol, for optimum chemo-prevention and benefits to mankind.

Keywords

α-Tocopherol Tocotrienols Chemo-prevention Absorption pathways Bioavailability 

References

  1. 1.
    Abe C, Ikeda S, Uchida T, Yamashita K, Ichikawa T (2007) Triton WR1339, an inhibitor of lipoprotein lipase, decreases vitamin E concentration in some tissues of rats by inhibiting its transport to liver. J Nutr 137:345–350PubMedGoogle Scholar
  2. 2.
    Anwar K, Iqbal J, Hussain MM (2007) Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. J Lipid Res 48:2028–2038CrossRefPubMedGoogle Scholar
  3. 3.
    Bjelakovic G, Nikolova D, Glund LL, Simonetti RG, Glund C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention—systematic review and meta-analysis. JAMA 297:842–857CrossRefPubMedGoogle Scholar
  4. 4.
    Bjørneboe A, Bjørneboe G-EA, Bodd E, Hagen BF, Kveseth N, Drevon CA (1986) Transport and distribution of α-tocopherol in lymph, serum and liver cells in rats. Biochim Biophys Acta 889:310–315CrossRefPubMedGoogle Scholar
  5. 5.
    Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo- controlled trial. Lancet 356:1213–1218CrossRefPubMedGoogle Scholar
  6. 6.
    Brigelius-Flohé R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A (2002) The European perspective on vitamin E, current knowledge and future research. Am J Clin Nutr 76:703–716PubMedGoogle Scholar
  7. 7.
    Brigelius-Flohé R (2003) Vitamin E and metabolism. Biochem Biophys Res Comm 305:737–740CrossRefPubMedGoogle Scholar
  8. 8.
    Brown MS, Goldstein JL (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52:223–261CrossRefPubMedGoogle Scholar
  9. 9.
    Burton GW, Ingold KU, Foster DO, Cheng SC, Webb A, Hughes L (1988) Comparison of free α-tocopherol and α-tocopheryl acetate as sources of vitamin E in rats and humans. Lipids 23:834–840CrossRefPubMedGoogle Scholar
  10. 10.
    Cheeseman KH, Holley AE, Kelly FJ, Wasil M, Hughes L, Burton G (1995) Biokinetics in humans of RRR-α-tocopherol: the free phenol, acetate ester, and succinate ester forms of vitamin E. Free Radic Biol Med 19:591–598CrossRefPubMedGoogle Scholar
  11. 11.
    Chun J, Lee J, Ye L, Exler J, Eitenmiller RR (2006) Tocopherol and tocotrienol contents of raw and processed fruits and vegetables in the United States diet. J Food Compos Anal 19:196–204CrossRefGoogle Scholar
  12. 12.
    Collins EG, Langbein WE, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN (2003) Polestriding exercise and vitamin E for management of peripheral vascular disease. Med Sci Sports Exerc 35:384–393CrossRefPubMedGoogle Scholar
  13. 13.
    Desnuelle C, Dib M, Garrel C, Favier A, ALS Riluzole-Tocopherol Study Group (2001) A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2:9–18CrossRefPubMedGoogle Scholar
  14. 14.
    Eitsuka T, Nakagawa K, Miyazawa T (2006) Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem Biophys Res Comm 348:170–175CrossRefPubMedGoogle Scholar
  15. 15.
    Fairus S, Nor RM, Cheng HM, Sundrum K (2006) Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of α-tocopherol. Am J Clin Nutr 84:835–842PubMedGoogle Scholar
  16. 16.
    Fiorentino A, Mastellone C, D’Abrosca B, Pacifico S, Scognamiglio M, Cefareli G, Caputo R, Monaco P (2009) δ-Tocomonoenol: a new vitamin E from kiwi (Actinidia chinensis) fruits. Food Chem 115:187–192CrossRefGoogle Scholar
  17. 17.
    de Gaetano G, Collaborative Group of The Primary Prevention Project (PPP) (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357:89–95CrossRefPubMedGoogle Scholar
  18. 18.
    Gillilan RE, Mondell B, Warbasse JR (1997) Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 93:444–449CrossRefGoogle Scholar
  19. 19.
    Gotoda T, Arita M, Arai H, Ionue K, Yokota T, Fukuo Y, Yazaki Y, Yamada N (1995) Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the α-tocopherol-transfer protein. N Engl J Med 333:1313–1318CrossRefPubMedGoogle Scholar
  20. 20.
    Graat JM, Schouten EG, Kok FJ (2002) Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 288:715–721CrossRefPubMedGoogle Scholar
  21. 21.
    Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M, Hager C, Ludolph AC, The German Vitamin E/ALS Study Group (2005) High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm 112:649–660CrossRefPubMedGoogle Scholar
  22. 22.
    Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (GISSI) (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447–455CrossRefGoogle Scholar
  23. 23.
    Guthrie N, Gapor A, Chambers AF, Carroll KK (1997) Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J Nutr 127:544S–548SPubMedGoogle Scholar
  24. 24.
    Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11:298–300PubMedGoogle Scholar
  25. 25.
    Hentati A, Deng H-X, Hung W-Y, Nayer M, Ahmad MS, He X, Tim R, Stumpf DA, Siddique T (1996) Human α-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency. Ann Neurol 39:295–300CrossRefPubMedGoogle Scholar
  26. 26.
    Herrera E, Barbas C (2001) Vitamin E: action, metabolism and perspectives. J Physiol Biochem 57:43–56CrossRefGoogle Scholar
  27. 27.
    Hodis HN, Mack WJ, Labree L, Mahrer PR, Sevanian A, Liu C-R, Liu C-H, Hwang J, Selzer RH, Azen SP, VEAPS Research Group (2002) Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106:1453–1459CrossRefPubMedGoogle Scholar
  28. 28.
    Horwitt MK (2001) Critique of the requirement for vitamin E. Am J Clin Nutr 73:1003–1005PubMedGoogle Scholar
  29. 29.
    Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T (1997) Affinity for α-tocopherol transfer protein as determinant of the biological activities of vitamin E analogs. FEBS Lett 409:105–108CrossRefPubMedGoogle Scholar
  30. 30.
    Huang H-Y, Appel LJ (2003) Supplementation of diets with α-tocopherol reduces serum concentrations of γ- and δ-tocopherol in humans. J Nutr 133:3137–3140PubMedGoogle Scholar
  31. 31.
    Hussain MM, Shi J, Dreizen P (2003) Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res 44:22–32CrossRefPubMedGoogle Scholar
  32. 32.
    Ikeda I, Imasato Y, Sasaki E, Sugano M (1996) Lymphatic transport of alpha-, gamma- and delta-tocotrienols and alpha-tocopherol in rats. Int J Vit Nutr Res 66:217–221Google Scholar
  33. 33.
    Ikeda S, Tohyama T, Yoshimura H, Hamamura K, Abe K, Yamashita K (2003) Dietary α-tocopherol decreases α-tocotrienol but not γ-tocotrienol concentration in rats. J Nutr 133:428–434PubMedGoogle Scholar
  34. 34.
    Institute of Medicine (2000) Dietary reference intake of vitamin C, vitamin E, selenium and carotinoids. Food and Nutrition Board. National Academy Press, Washington DC, pp 186–283Google Scholar
  35. 35.
    IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) Nomenclature of tocopherols and related compounds. Recommendations 1981. [http://www.chem.qmul.ac.uk/iupac/misc/toc.html]
  36. 36.
    Jishage K, Arita M, Igarashi K, Iwata T, Watanabe M, Ogawa M, Ueda O, Kamada N, Inoue K, Arai H, Suzuki H (2001) α-Tocopherol transfer protein is important for the development of placental labyrinthine trophoblasts in mice. J Biol Chem 276:1669–1672CrossRefPubMedGoogle Scholar
  37. 37.
    Kaempt-Rotzoll DE, Traber MG, Arai H (2003) Vitamin E and transfer proteins. Curr Opin Lipidol 14:249–254CrossRefGoogle Scholar
  38. 38.
    Kayden HJ, Traber MG (1993) Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 34:343–358PubMedGoogle Scholar
  39. 39.
    Khanna S, Patel V, Rink C, Roy S, Sen CK (2005) Delivery of orally supplemented α-tocotrienol to vital organs of rats and tocopherol-transfer protein deficient mice. Free Rad Biol Med 39:1310–1319CrossRefPubMedGoogle Scholar
  40. 40.
    Khosla P, Patel V, Whinter JM, Khanna S, Rakhkovskaya M, Roy S, Sen C (2006) Postprandial levels of the natural vitamin E tocotrienol in human circulation. Antioxid Redox Signal 8:1059–1068CrossRefPubMedGoogle Scholar
  41. 41.
    Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JMO, Ross C, Sleight P, Probstfield J, Dagenais GR, Hope And Hope Too Trial Investigators (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347CrossRefPubMedGoogle Scholar
  42. 42.
    Manuel-y-Keenoy B, Vinckx M, Vertommen J, van Gaal L, de Leeuw I (2004) Impact of vitamin E supplementation on lipoprotein peroxidation and composition in type 1 diabetic patients treated with atorvastatin (DATOR). Atherosclerosis 175:369–376CrossRefPubMedGoogle Scholar
  43. 43.
    Marras C, Mcdermott MP, Rochon PA, Tanner CM, Naglie G, Rudolph A, Lang AE, Parkinson Study Group (2005) Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Neurology 64:87–93PubMedGoogle Scholar
  44. 44.
    Matsumoto A, Takahashi S, Nakano K, Kijima S (1995) Identification of new vitamin E in plant oil. J Jpn Oil Chem Soc 44:593–597Google Scholar
  45. 45.
    de la Maza MP, Petermann M, Bunout D, Hirsch S (1995) Effects of long-term vitamin E supplementation in alcoholic cirrhotics. J Am Coll Nutr 14:192–196PubMedGoogle Scholar
  46. 46.
    McIntyre BS, Briski KP, Gapor A, Sylvester PW (2000) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224:292–301CrossRefPubMedGoogle Scholar
  47. 47.
    McNeil JJ, Robman L, Tikellis G, Sinclair MI, Mccarty CA, Taylor HR (2004) Vitamin E supplementation and cataract (VECAT): randomized controlled trial. Ophthalmology 111:75–84CrossRefPubMedGoogle Scholar
  48. 48.
    Mezey E, Potter JJ, Rennie-Tankersley L, Caballeria J, Pares A (2004) A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 40:40–46CrossRefPubMedGoogle Scholar
  49. 49.
    Meier R, Tomizaki T, Schulze-Briese C, Baumann U, Stocker A (2003) The molecular basis of vitamin E retention: structure of human α-tocopherol transfer protein. J Mol Biol 331:725–734CrossRefPubMedGoogle Scholar
  50. 50.
    Miller ER III, Pastor-Barriuso R, Dalal D, Riemerma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Int Med 142:37–46PubMedGoogle Scholar
  51. 51.
    Min CK, Kovall RA, Hendrikson WA (2003) Crystal structure of human α-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency. Proc Natl Acad Sci USA 100:14713–14718CrossRefPubMedGoogle Scholar
  52. 52.
    Minehira-Castelli K, Leonard SW, Walker QM, Traber MG, Young SG (2006) Absence of VLDL secretion does not affect α-tocopherol content in peripheral tissues. J Lipid Res 47:1733–1738CrossRefPubMedGoogle Scholar
  53. 53.
    Miyazawa T, Shibata T, Sookwong P, Kawakami Y, Eitsuka T, Asai A, Oikawa S, Nakagawa K (2009) Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol). J Nutr Biochem 20:79–86CrossRefPubMedGoogle Scholar
  54. 54.
    Mizushima Y, Nakagawa K, Shibata A, Awata Y, Kuriyama I, Shimazaki N, Koiwai O, Uchiyama Y, Sakaguchi K, Miyazawa T, Yoshida H (2006) Inhibitory effect of tocotrienol on eukaryotic DNA polymerase λ and angiogenesis. Biochem Biophys Res Comm 339:949–955CrossRefGoogle Scholar
  55. 55.
    Naito Y, Shimozama M, Kuroda M, Nakabe N, Manabe H, Katada K, Kokura S, Ichikawa H, Yoshida N, Naguchi N, Yoshikawa T (2005) Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180:19–25CrossRefPubMedGoogle Scholar
  56. 56.
    Nakagawa K, Shibata A, Yamashita S, Tsuzuki T, Kariya J, Oikawa S, Miyazawa T (2007) In vivo angiogenesis is suppressed by unsaturated vitamin E, tocotrienol. J Nutr 137:1938–1943PubMedGoogle Scholar
  57. 57.
    Nesaretnam K, Gomez PA, Selvaduray KR, Razak GA (2007) Tocotrienol levels in adipose tissue of benign and malignant breast lumps in patients in Malaysia. Asia Pac J Clin Nutr 16:498–504PubMedGoogle Scholar
  58. 58.
    Ouahchi K, Arita M, Kayden H, Hentati F, Hamida MB, Sokol R, Arai H, Inoue K, Mandel J-L, Koenig M (1995) Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nat Genet 9:141–145CrossRefPubMedGoogle Scholar
  59. 59.
    Panfili G, Fratianni A, Irano M (2003) Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. J Agric Food Chem 51:3940–3944CrossRefPubMedGoogle Scholar
  60. 60.
    Park SK, Saunders BG, Kline K (2010) Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast Cancer Res Treat doi: 10.1007/s10549-010-0786-2
  61. 61.
    Peralta EA, Viegas ML, Louis S, Engle DL, Dunnington GL (2006) Effect of vitamin E on tamoxifen-treated breast cancer cells. Surgery 140:607–615CrossRefPubMedGoogle Scholar
  62. 62.
    Peralta EA, Brewer AT, Louis S, Engle DL, Dunnington GL (2009) Vitamin E increases biomarkers of estrogen stimulation when taken with tamoxifen. J Surg Res 153:143–147CrossRefPubMedGoogle Scholar
  63. 63.
    Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ (2005) Alzheimer’s Disease Cooperative Study (ADCS2) Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352:2379–2388CrossRefPubMedGoogle Scholar
  64. 64.
    Qureshi AA, Pearce BC, Nor RM, Gapor A, Petersen DM, Elson CE (1996) Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl co-enzyme A reductase activity in chickens. J Nutr 126:389–394PubMedGoogle Scholar
  65. 65.
    Reboul E, Klein A, Bietrix F, Gleize B, Malezet-Desmoulins C, Schneider M, Margotat A, Lagrost L, Collet X, Borel P (2006) Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem 281:4739–4745CrossRefPubMedGoogle Scholar
  66. 66.
    Rigotti A (2007) Absorption, transport and tissue delivering of vitamin E. Mol Aspects Med 28:423–436CrossRefPubMedGoogle Scholar
  67. 67.
    Ryynänen M, Lampi A-M, Salo-Väänänen P, Ollilainen V, Piironen V (2004) A small-scale sample preparation method with HPLC analysis for determination of tocopherols and tocotrienols in cereals. J Food Compos Anal 17:749–765CrossRefGoogle Scholar
  68. 68.
    Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen T-P, Valkonen V-P, Ristonmaa U, Lakka H-M, Vanharanta M, Salonen JT, Poulsen HE (2003) Antioxidant supplementation in atherosclerosis prevention study (ASAP): six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107:947–953CrossRefPubMedGoogle Scholar
  69. 69.
    Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease: the Alzheimer’s Disease Cooperative Study (ADCS1). N Engl J Med 336:1216–1222CrossRefPubMedGoogle Scholar
  70. 70.
    Scientific opinion of the panel on food additives, flavourings, processing aids and materials in contact with food on a request from the commission on mixed tocopherols, tocotrienol tocopherol and tocotrienols as sources for vitamin E (2008) EFSA J 640: 1–34Google Scholar
  71. 71.
    Sen CK, Khanna S, Roy S, Packer L (2000) Molecular basis of vitamin E action. J Biol Chem 275:13047–13055Google Scholar
  72. 72.
    Sen CK, Khanna S, Roy S (2007) Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects of Med 28:693–728Google Scholar
  73. 73.
    Schonfeld G, Bell E, Alpers DH (1978) Intestinal apoproteins during fat absorption. J Clin Invest 61:1539–1550CrossRefPubMedGoogle Scholar
  74. 74.
    Shirode AB, Sylvester PW (2009) Synergistic anticancer effects of combined γ-tocotrienol and celecoxib treatment are associated with suppressing in Akt and NFκB signaling. Biomedic Pharmacother (in press) doi: 10.1016/j.biopha.2009.09.018
  75. 75.
    Stalenhoef AFH, Malloy MJ, Kane JP, Havel RJ (1984) Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci USA 81:1839–1843CrossRefPubMedGoogle Scholar
  76. 76.
    Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781–786CrossRefPubMedGoogle Scholar
  77. 77.
    Takagi H, Kakizaki S, Sohara N, Sato K, Tsukioka G, Tago Y, Konaka K, Kabeya K, Kaneko M, Takayama H, Hashimoto Y, Yamada T, Takahashi H, Shimojo H, Nagamine T, Mori M (2003) Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis. Int J Vit Nutr Res 73:411–415CrossRefGoogle Scholar
  78. 78.
    Takamatsu S, Takamatsu M, Satoh K, Imaizumi T, Yoshida H, Hiramoto M, Koyama M, Ohgushi Y, Mizuno S (1995) Effects on health of dietary supplementation with 100 mg d-alpha-tocopheryl acetate, daily for 6 years. J Int Med Res 23:342–357PubMedGoogle Scholar
  79. 79.
    Thiele JJ, Traber MG, Packer L (1998) Depletion of human stratum corneum vitamin E: an early and sensitive in vivo marker of UV induced photo-oxidation. J Invest Dermatol 110:756–761CrossRefPubMedGoogle Scholar
  80. 80.
    Thiele JJ, Weber SU, Packer L (1999) Sebaceous gland secretion is a major physiologic route of vitamin E delivery to skin. J Invest Dermatol 113:1006–1010CrossRefPubMedGoogle Scholar
  81. 81.
    Traber MG, Kayden HJ (1989) Preferential incorporation of α-tocopherol vs. γ-tocopherol in human lipoproteins. Am J Clin Nutr 49:517–526PubMedGoogle Scholar
  82. 82.
    Traber MG, Burton GW, Ingold KU, Kayden HJ (1990) RRR- and SRR-α-Tocopherols are secreted without discrimination in human chylomicrons, but RRR-α-tocopherol is preferentially secreted in very low density lipoproteins. J Lipid Res 31:675–685PubMedGoogle Scholar
  83. 83.
    Traber MG, Lane JC, Lagmay NR, Kayden HJ (1992) Studies on the transfer of tocopherol between lipoproteins. Lipids 27:657–663CrossRefPubMedGoogle Scholar
  84. 84.
    Traber MG (1996) Biokinetics of vitamin E. In: Cadenas E, Packer L (eds) Handbook of antioxidants. Marcel Dekker Inc., New York, pp 43–61Google Scholar
  85. 85.
    Traber MG (2004) The ABCs of vitamin E and beta-carotene absorption. Am J Clin Nutr 80:3–4PubMedGoogle Scholar
  86. 86.
    Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P, ATBC Study Group (2003) Incidence of cancer and mortality following alpha-tocopherol and beta-carotene (ATBC) supplementation: a postintervention follow-up. JAMA 290:476–485CrossRefPubMedGoogle Scholar
  87. 87.
    de Waart FG, Kok FJ, Smilde TJ, Hijmans A, Wollersheim H, Stalenhoef AF (2001) Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis 158:227–231CrossRefPubMedGoogle Scholar
  88. 88.
    Wali VB, Sylvester PW (2007) Synergistic antiproliferative effects of γ-tocotrienol and statin treatment on mammary tumor cells. Lipids 42:1113–1123CrossRefPubMedGoogle Scholar
  89. 89.
    Wali VB, Bachawal SV, Sylvester PW (2009) Suppression in mevalonate synthesis mediates antitumor effects of combined statin and γ-tocotrienols treatment. Lipids 44:925–934CrossRefPubMedGoogle Scholar
  90. 90.
    Whatson RR, Preedy VR (eds) (2008) Tocotrienols: vitamin E beyond tocopherols. AOCS Press, UrbanaGoogle Scholar
  91. 91.
    Wluka AE, Stuckey S, Brand C, Cicuttini FM (2002) Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: a 2 year double blind randomized placebo controlled study. J Rheumatol 29:2585–2591PubMedGoogle Scholar
  92. 92.
    Wu JH, Croft KD (2007) Review: vitamin E metabolism. Mol Aspects Med 2007(28):437–452CrossRefGoogle Scholar
  93. 93.
    Yamamoto Y, Fujisawa A, Hara A, Dunlap WC (2001) An unusual vitamin E constituent (α-tocomonoenol) provides enhanced antioxidant protection in marine organisms adapted to cold-water environments. Proc Natl Acad Sci USA 23:13144–13148CrossRefGoogle Scholar
  94. 94.
    Yap SP, Yuen KH, Wong JW (2001) Pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienol under different food status. J Pharm Pharmacol 53:67–71CrossRefPubMedGoogle Scholar
  95. 95.
    Yap WN, Chang PN, Han HY, Lee DTW, Ling MT, Wong YC, Yap YL (2008) γ-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br J Cancer 99:1–10CrossRefGoogle Scholar
  96. 96.
    Young SG (1990) Recent progress in understanding apolipoprotein B. Circulation 82:1574–1594PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Palm Nutraceuticals Sdn. Bhd.Kota TinggiMalaysia

Personalised recommendations